Search the Newsreel

Sophia Genetics SA (SOPH) Financial Health: Profitability & Balance Sheet Analysis

Sophia Genetics SA (SOPH) currently holds a financial score of 6.49, placing it 348th out of 485 in the Software & IT Services industry. The company's financial status is stable, though its operating efficiency is low. In its latest quarter, Sophia Genetics SA reported …

Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down

Koninklijke Philips N.V. PHG reported second-quarter 2026 adjusted earnings of €0.49 per share, up 36.1% from €0.36 a year ago. The improvement reflected higher sales, productivity measures and a U.S. tariff refund benefit. Sales increased 0.5% year over year to €4.36 billion. Comparable sales …

Philips Gets a Tariff Refund, Not a Clean Bill of Health

Philips Gets a Tariff Refund, Not a Clean Bill of Health - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $28,300.00 in Stock

Philippe Menu, an insider at SOPHiA GENETICS (NASDAQ:SOPH), sold 5,000 shares of the company's stock for $28,300 at an average price of $5.66. This transaction was part of a pre-arranged Rule 10b5-1 trading plan and reduced his position by 2.19%. The company's stock is …

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 24,381 Shares

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Jurgi Camblong sold 24,381 shares of the company's stock for $153,356.49, reducing his ownership by 0.69%. This sale, part of a Rule 10b5-1 plan, is one of several recent transactions totaling over 150,000 shares sold since June. The stock currently …

Koninklijke Philips NV (PHG) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst ...

This article first appeared on GuruFocus. Comparable Sales Growth: Increased by 4% in Q2, driven by growth across all segments. Adjusted EBITDA Margin: Increased to 16.4%, including a tariff refund benefit; underlying margin was 12.2% without the benefit. Free Cash Flow: EUR220 million, including …

SOPHiA GENETICS (SOPH) Expected to Post Earnings on Tuesday

SOPHiA GENETICS (SOPH) is scheduled to release its Q2 2026 earnings before market open on Tuesday, August 4th. Analysts forecast a loss of $0.21 per share and revenue of $21.72 million for the quarter. The company's stock recently opened at $5.65, and insider sales …

Philips forecasts 3%-4.5% comparable sales growth and €1.5B-€1.7B free cash flow, reflecting tariff refund

Earnings Call Insights: Koninklijke Philips N.V. (PHG) Q2 2026 MANAGEMENT VIEW * “We delivered in line with our expectations in a dynamic external environment,” said CEO Roy Jakobs (President, CEO & Chairman of the Board of Management Roy Jakobs), citing “comparable sales by 4%” …

Philips falls 9% as weak orders, China concerns overshadow outlook hike

This article first appeared on GuruFocus. Philips (NYSE:PHG), a Dutch healthcare-technology company producing medical equipment and consumer-health products, fell 9% in Tuesday's European trading after reporting weaker-than-expected orders and warning about increasingly difficult conditions in China. The decline pushed the shares to their lowest …

US tariffs refund boosts Philips

Philips is turning the page on its sleep machine scandal (Sem van der Wal) Dutch healthcare technology giant Philips bolstered its earnings outlook Tuesday after obtaining $158 million in US tariff refunds, winning back almost all of the cash levied, director general Roy Jakobs …

Jurgi Camblong Sells 20,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

Philips Q2 Profit Climbs, Orders Down; Lifts FY26 Adj. EBITA View, Backs Sales Forecast

(RTTNews) - Dutch consumer electronics giant Koninklijke Philips N.V. (PHGFF.PK, PHG) reported Tuesday a significant growth in second-quarter earnings, mainly on US tariff refund and slightly higher net sales. Meanwhile, comparable order intake declined 1 percent due to timing of certain large orders. Further, …

Philips reports Q2 results; reaffirms FY2026 outlook

* Philips press release [https://seekingalpha.com/pr/20596337-philips-delivers-solid-comparable-sales-growth-and-margin-in-q2-reiterates-full-year] (PHG [https://seekingalpha.com/symbol/PHG]): Q2 Revenue of €4.4B (+0.9% Y/Y), reflecting 4% comparable sales growth. * Comparable order intake declined 1%, due to timing of certain large orders. * Disciplined cost management and productivity initiatives delivered EUR 132 million in savings …

Koninklijke Philips N.V. bestätigt Ergebnisprognose für das Geschäftsjahr 2026

Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund

Royal Philips July 27, 2026 Q2 2026 Group performance Comparable order intake declined 1%, due to timing of certain large orders Group sales of EUR 4.4 billion, reflecting 4% comparable sales growth Income from operations of EUR 609 million, including US tariff refund benefit …

Sophia Genetics SA (SOPH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sophia Genetics SA (SOPH), listing its major shareholders and their proportional holdings, as well as a breakdown of shareholder types. It also provides institutional shareholding data over recent quarters, showing the number of institutions, shares held, and …

Sophia Genetics SA (SOPH) Cash Flow Statement

This article provides the quarterly and annual cash flow statements for Sophia Genetics SA (SOPH), including operating, investing, and financing cash flows, along with related frequently asked questions. It details key financial figures such as net income, capital expenditures, and free cash flow over …

Global Healthcare IT Market to Reach $961.26 Billion by 2030, Driven by AI, EHR and Telehealth Adoption

Company Logo Healthcare providers remain the largest end-user segment, while telehealth leads clinical healthcare IT. Asia Pacific is expected to record the highest growth, supported by improving infrastructure and HCIT adoption. Key players include Optum, Oracle, Philips, Cognizant and GE Healthcare. Healthcare IT MarketHealthcare …

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Rating of "Hold" by Brokerages

SOPHiA GENETICS SA (NASDAQ:SOPH) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $9.00. While the company's latest quarterly revenue exceeded estimates, it reported a wider-than-expected loss and is still projected to remain unprofitable this year. Insiders have …

SOPHiA GENETICS (NASDAQ:SOPH) Raised to "Hold" at Zacks Research

Zacks Research upgraded SOPHiA GENETICS (NASDAQ:SOPH) to a "Hold" rating, though the stock has been trading down 1.5% near its 52-week high. Despite some positive sentiment from other analysts regarding its long-term growth and potential profitability by FY2028, the company continues to post weak …

Shanghai Droi Technology Introduces DroiClaw AI-Native Operating System

SHANGHAI, July 23, 2026--(BUSINESS WIRE)--Shanghai Droi Technology has formally introduced DroiClaw, its new-generation smart terminal operating system designed to advance the global AI-device market. Known domestically as Zhuge, the platform officially launched in June 2026, debuting as a preinstalled operating system on newly released …

HC Wainwright Estimates SOPHiA GENETICS Q2 Earnings

HC Wainwright has reiterated a "Buy" rating and a $12.00 price target for SOPHiA GENETICS (NASDAQ:SOPH), estimating a Q2 2026 loss of $0.15 per share. The firm projects profitability for SOPHiA GENETICS by FY2028. Despite missing Q2 2026 EPS expectations at $(0.27), the company …

3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Luckily for you, we built StockStory to help …

SOPHiA GENETICS (SOPH) affiliate files to sell 37,000 founders shares on NASDAQ

SOPHiA GENETICS (SOPH) has announced that an affiliate, through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed to sell up to 37,000 founders shares on NASDAQ, valued at $234,210.00. The SEC filing also details previous sales by Jurgi Camblong under a Rule …

Philips receives FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor

Royal Philips Philips SpO₂ Clip SensorPhilips SpO₂ Clip Sensor July 21, 2026 New sensor advances pulse oximetry reliability for diverse patient populations through innovation and rigorous validation. Cambridge, MASS –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced FDA …

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026

SOPHiA GENETICS announced that it will release its financial results for the second quarter of 2026 before U.S. markets open on Tuesday, August 4, 2026. The company will also host a conference call on the same day at 8:00 a.m. EDT / 2:00 p.m. …

SOPHiA GENETICS sets 8 a.m. webcast for Q2 results call

SOPHiA GENETICS (Nasdaq: SOPH) will release its second quarter 2026 financial results before U.S. markets open on August 4, 2026. The company will host a conference call and live webcast at 8:00 a.m. EDT / 2:00 p.m. CET to discuss these results and its …

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month High - Time to Buy?

SOPH insider (NASDAQ: SOPH) details planned stock and option-related sales

An insider at SOPHiA GENETICS SA (NASDAQ: SOPH) has filed a Form 144 detailing planned sales of common stock. Jurgi Camblong plans to sell 4,581 shares from an option exercise and 19,800 founder shares, with recent sales already conducted under a Rule 10b5-1 trading …

HC Wainwright Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)

HC Wainwright has initiated coverage on SOPHiA GENETICS (NASDAQ:SOPH) with a "buy" rating and a $12 price target, indicating a potential 104% upside. This positive outlook, shared by BTIG Research, contrasts with a "sell" rating from Weiss Ratings, leading to an overall "Moderate Buy" …

H.C. Wainwright initiates Sophia Genetics stock with buy rating By Investing.com

H.C. Wainwright has initiated coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Buy rating and a $12.00 price target, suggesting over 100% upside. The company operates an AI-driven genomics platform used by hospitals and labs globally, generating recurring revenue. Sophia Genetics recently closed …

Philips (ENXTAM:PHIA) Stock Looks Fairly Priced Despite New AI Ultrasound Launch

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Koninklijke Philips stock has recovered on a 1 year view but, after a 5 year decline in total return, the current valuation signals suggest the …

Koninklijke Philips (ENXTAM:PHIA) Expands Virtual Monitoring, Is The Stock Still Undervalued?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Koninklijke Philips (ENXTAM:PHIA) is back in focus after West Tennessee Healthcare selected Philips and hellocare.ai to roll out virtual monitoring across 127 ICU …

SOPHiA GENETICS prices $50M public offering at $4.75 per share

SOPHiA GENETICS has priced a public offering of 10,526,316 shares at $4.75 per share. The offering is expected to raise approximately $50 million in gross proceeds. This financial move aims to secure capital for the company.

Senzime AB (SNZZF) Q2 2026 Earnings Call Highlights: Strategic Partnerships and Financial ...

This article first appeared on GuruFocus. Release Date: July 16, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Senzime AB (SNZZF) reported a 15% decrease in operating expenses, demonstrating effective cost management. The …

SOPHiA GENETICS SA 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:SOPH) 2026-05-07